Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia
- PMID: 1151528
- DOI: 10.1002/path.1711160204
Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia
Abstract
The interrelationships between liver iron concentration, the duration of iron-loading, and hepatic fibrosis, assessed morphometrically, have been studied in 32 specimens of liver obtained from 19 heavily transfused patients with thalassaemia major whose age ranged from 4 to 19 yr. Similar observations were made in a matched group of thalassaemic patients treated with long-term chelation therapy. The degree of liver damage ranged from very slight increase in fibrous tissue to severe fibrosis and cirrhosis. The severity of the fibrosis was closely correlated both with liver iron concentration and with age. While the relationship between fibrosis and age was linear, both the severity and the rate of fibrosis were exponentially related to liver iron concentration, damage accelerating as liver iron concentration exceeded 3 per cent, dry weight. By producing a modest but significant reduction in liver iron concentration chelation therapy resulted in a disproportionate but predictable retardation in the progression of the fibrosis. The factors affecting the distribution of iron between parenchymal and reticuloendothelial cells were also examined. In general stainable iron was uniformly distributed between parenchymal and reticuloendothelial cells from the early stages of iron-loading. Parenchymal siderosis was relatively heavier in splenectomised patients and in patients with liver iron concentrations above 3 per cent, dry weight than in non-splenectomised patients or patients with liver iron levels of less than 3 per cent, dry weight, but this did not affect the severity of the fibrosis. The relevance of these findings to the traditional concepts of the pathology of transfusional siderosis is discussed.
Similar articles
-
Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.Haematologica. 1995 Sep-Oct;80(5):398-404. Haematologica. 1995. PMID: 8566878
-
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.Haematologica. 2008 Aug;93(8):1243-6. doi: 10.3324/haematol.12554. Epub 2008 Jun 12. Haematologica. 2008. PMID: 18556410
-
Liver iron overload and liver fibrosis in thalassemia.Bone Marrow Transplant. 1993;12 Suppl 1:29-31. Bone Marrow Transplant. 1993. PMID: 8374556 No abstract available.
-
Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia.Best Pract Res Clin Haematol. 2002 Jun;15(2):329-68. Best Pract Res Clin Haematol. 2002. PMID: 12401311 Review.
-
Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.Semin Hematol. 1995 Oct;32(4):304-12. Semin Hematol. 1995. PMID: 8560288 Review.
Cited by
-
Perinatal hemochromatosis. Clinical, morphologic, and quantitative iron studies.Am J Pathol. 1987 Sep;128(3):538-54. Am J Pathol. 1987. PMID: 3307444 Free PMC article.
-
Myocardial iron deposition in beta-thalassemia studied by magnetic resonance imaging.Int J Card Imaging. 1998 Apr;14(2):117-22. doi: 10.1023/a:1005922016048. Int J Card Imaging. 1998. PMID: 9617642
-
Hormonal changes in thalassaemia major.Arch Dis Child. 1976 Nov;51(11):828-36. doi: 10.1136/adc.51.11.828. Arch Dis Child. 1976. PMID: 1008588 Free PMC article.
-
Quantitative MRI of diffuse liver diseases: techniques and tissue-mimicking phantoms.MAGMA. 2023 Aug;36(4):529-551. doi: 10.1007/s10334-022-01053-z. Epub 2022 Dec 14. MAGMA. 2023. PMID: 36515810 Free PMC article. Review.
-
Pathologic aspects of cirrhosis. A review.Am J Pathol. 1977 Apr;87(1):228-64. Am J Pathol. 1977. PMID: 322505 Free PMC article. Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources